Throughout the years, SABCS has shown how tucatinib has progressed into a potential frontline therapy for HER2-positive breast cancer.
Researchers are exploring which cancer types have higher incidence in people under 50, what may be causing this rise...
This month, the AACR's journals editors highlighted studies on U.S. cancer mortality hotspots, chemotherapy-induced hearing loss, and more.
Advances in cardio-oncology are redefining cancer care, shaping safer treatments to protecting patients’ hearts.
AACR Global Scholar-in-Training Award recipients shared how the program’s professional development opportunities have impacted their careers.
This post examines ultraprocessed foods and what current research shows about how they impact health and cancer risk.
New AI-driven models unveiled at the AACR Annual Meeting 2025 could revolutionize how we diagnose sarcomas in children.
The chairs for AACR on Campus in Malaysia share how early-career researchers can benefit from the programs in Kuala...
During his Pezcoller Foundation-AACR Award lecture, Douglas Hanahan, PhD, FAACR, highlighted ways to overcome systemic immunosuppression.
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
A single-cell atlas helped clarify diverse forms of acute myeloid leukemia, with potential implications for improving diagnostic, prognostic, and...